Sequence recognition of α-LFA-1-derived peptides by ICAM-1 cell receptors: Inhibitors of T-cell adhesion

Chemical Biology and Drug Design

Volumn 70, Issue 3, 2007, Pages 237-246

  Yusuf Makagiansar, Helena ^a,b   Yakovleva, Tatyana V ^a   Tejo, Bimo A ^a   Jones, Karen ^a,c   Hu, Yongbo ^a   Verkhivker, Gennady M ^a   Audus, Kenneth L ^a   Siahaan, Teruna J ^a  

^a UNIVERSITY OF KANSAS   (United States)

^b BIOGEN   (United States)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

Autoimmune diseases; Cyclic peptide; ICAM 1; LFA 1 peptides; T cell adhesion

Indexed keywords

ASPARTYLGLYCYLGLUTAMYLALANYLTHREONYLASPARTIC ACID; HEXAPEPTIDE; INTERCELLULAR ADHESION MOLECULE 1; ISOLEUCYLTHREONYLASPARTYLGLYCYLGLUTAMYLALANINE; UNCLASSIFIED DRUG;

ARTICLE; BINDING KINETICS; BIOLOGICAL ACTIVITY; CELL ASSAY; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG ACTIVITY; DRUG BINDING SITE; DRUG PROTEIN BINDING; EXPERIMENTAL STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKOCYTE ADHERENCE; PNEUMONIA; PRIORITY JOURNAL; SEQUENCE ANALYSIS; STRUCTURE ACTIVITY RELATION; T LYMPHOCYTE; WESTERN BLOTTING;

AMINO ACID SEQUENCE; CELL ADHESION; CELL LINE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON TYPE II; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MODELS, MOLECULAR; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, TERTIARY; T-LYMPHOCYTES;

EID: 34548151322     PISSN: 17470277     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2007.00549.x     Document Type: Article

References (52)

1. Yusuf-Makagiansar H., Anderson M.E., Yakovleva T.V., Murray J.S., Siahaan T.J. (2002) Inhibition of LFA-1/ICAM-1 and VLA-4/VCAM-1 as a therapeutic approach to inflammation and autoimmune diseases. Med Res Rev 22 : 146 167.
2. Behrend M. (2000) Immune-adhesion molecules in the prevention of allograft rejection and reperfusion injury. Expert Opin Investig Drugs 9 : 789 805.
3. Dustin M.L. (2002) The immunological synapse. Arthritis Res Ther 4 (Suppl. 3 S119 S125.
4. Davis D.M., Dustin M.L. (2004) What is the importance of the immunological synapse? Trends Immunol 25 : 323 327.
5. Grakoui A., Bromley S.K., Sumen C., Davis M.M., Shaw A.S., Allen P.M., Dustin M.L. (1999) The immunological synapse: a molecular machine controlling T cell activation. Science 285 : 221 227.
6. Bromley S.K., Dustin M.L. (2002) Stimulation of naive T-cell adhesion and immunological synapse formation by chemokine-dependent and -independent mechanisms. Immunology 106 : 289 298.
7. Dustin M.L., Shaw A.S. (1999) Costimulation: building an immunological synapse. Science 283 : 649 650.
8. Ragazzo J.L., Ozaki M.E., Karlsson L., Peterson P.A., Webb S.R. (2001) Costimulation via lymphocyte function-associated antigen 1 in the absence of CD28 ligation promotes anergy of naive CD4+ T cells. Proc Natl Acad Sci U S A 98 : 241 246.
9. Isobe M., Yagita H., Okumura K., Ihara A. (1992) Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. Science 255 : 1125 1127.
10. Takazawa K., Hosoda Y., Bashuda H., Seino K., Yagita H., Tamatani T., Miyasaka M., Okumura K. (1996) Synergistic effects of mycophenolate mofetil (MMF, RS-61443) and anti-LFA-1/ICAM-1 monoclonal antibodies on the prolongation of heart allograft survival in rats. Transplant Proc 28 : 1980 1981.
11. Barouch F.C., Miyamoto K., Allport J.R., Fujita K., Bursell S.E., Aiello L.P., Luscinskas F.W., Adamis A.P. (2000) Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes. Invest Ophthalmol Vis Sci 41 : 1153 1158.
12. Moriyama H., Yokono K., Amano K., Nagata M., Hasegawa Y., Okamoto N., Tsukamoto K. et al. (1996) Induction of tolerance in murine autoimmune diabetes by transient blockade of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway. J Immunol 157 : 3737 3743.
13. Schulze-Koops H., Lipsky P.E., Kavanaugh A.F., Davis L.S. (1995) Elevated Th1- or Th0-like cytokine mRNA in peripheral circulation of patients with rheumatoid arthritis. Modulation by treatment with anti-ICAM-1 correlates with clinical benefit. J Immunol 155 : 5029 5037.
14. Kavanaugh A.F., Davis L.S., Jain R.I., Nichols L.A., Norris S.H., Lipsky P.E. (1996) A phase I/II open label study of the safety and efficacy of an anti-ICAM-1 (intercellular adhesion molecule-1; CD54) monoclonal antibody in early rheumatoid arthritis. J Rheumatol 23 : 1338 1344.
15. Gottlieb A.B., Krueger J.G., Wittkowski K., Dedrick R., Walicke P.A., Garovoy M. (2002) Psoriasis as a model for T-cell-mediated disease: immunobiologic and clinical effects of treatment with multiple doses of efalizumab, an anti-CD11a antibody. Arch Dermatol 138 : 591 600.
16. Papp K., Bissonnette R., Krueger J.G., Carey W., Gratton D., Gulliver W.P., Lui H. et al. (2001) The treatment of moderate to severe psoriasis with a new anti-CD11a monoclonal antibody. J Am Acad Dermatol 45 : 665 674.
17. Gordon K.B., Papp K.A., Hamilton T.K., Walicke P.A., Dummer W., Li N., Bresnahan B.W., Menter A. (2003) Efalizumab for patients with moderate to severe plaque psoriasis: a randomized controlled trial. JAMA 290 : 3073 3080.
18. Cather J.C., Cather J.C., Menter A. (2003) Modulating T cell responses for the treatment of psoriasis: a focus on efalizumab. Expert Opin Biol Ther 3 : 361 370.
19. Lebwohl M., Tyring S.K., Hamilton T.K., Toth D., Glazer S., Tawfik N.H., Walicke P., Dummer W., Wang X., Garovoy M.R., Pariser D. (2003) A novel targeted T-cell modulator, efalizumab, for plaque psoriasis. N Engl J Med 349 : 2004 2013.
20. Shimaoka M., Springer T.A. (2004) Therapeutic antagonists and the conformational regulation of the beta2 integrins. Curr Top Med Chem 4 : 1485 1495.
21. Tibbetts S.A., Chirathaworn C., Nakashima M., Jois D.S., Siahaan T.J., Chan M.A., Benedict S.H. (1999) Peptides derived from ICAM-1 and LFA-1 modulate T cell adhesion and immune function in a mixed lymphocyte culture. Transplantation 68 : 685 692.
22. Tibbetts S.A., Seetharama Jois D., Siahaan T.J., Benedict S.H., Chan M.A. (2000) Linear and cyclic LFA-1 and ICAM-1 peptides inhibit T cell adhesion and function. Peptides 21 : 1161 1167.
23. 2 integrin lymphocyte function-associated antigen-1 contains a binding site for ligand intercellular adhesion molecule-1. J Biol Chem 269 : 12395 12398.
24. 2) integrin. Proc Natl Acad Sci U S A 92 : 10277 10281.
25. Stanley P., Bates P.A., Harvey J., Bennett R.I., Hogg N. (1994) Integrin LFA-1 alpha subunit contains an ICAM-1 binding site in domains V and VI. EMBO J 13 : 1790 1798.
26. 2, CD11a/CD18) and MAC-1 (alpha M beta 2, CD11b/CD18). J Biol Chem 270 : 94 98.
27. 2 ligand interactions. J Biol Chem 271 : 23729 23736.
28. Yusuf-Makagiansar H., Makagiansar I.T., Hu Y., Siahaan T.J. (2001) Synergistic inhibitory activity of alpha- and beta-LFA-1 peptides on LFA-1/ICAM-1 interaction. Peptides 22 : 1955 1962.
29. Yusuf-Makagiansar H., Siahaan T.J. (2001) Binding and internalization of an LFA-1-derived cyclic peptide by ICAM receptors on activated lymphocyte: a potential ligand for drug targeting to ICAM-1-expressing cells. Pharm Res 18 : 329 335.
30. Huang M., Matthews K., Siahaan T.J., Kevil C.G. (2005) Alpha L-integrin I domain cyclic peptide antagonist selectively inhibits T cell adhesion to pancreatic islet microvascular endothelium. Am J Physiol Gastrointest Liver Physiol 288 : G67 G73.
31. Barnard A.L., Igakura T., Tanaka Y., Taylor G.P., Bangham C.R. (2005) Engagement of specific T-cell surface molecules regulates cytoskeletal polarization in HTLV-1-infected lymphocytes. Blood 106 : 988 995.
32. Li P., Roller P.P. (2002) Cyclization strategies in peptide derived drug design. Curr Top Med Chem 2 : 325 341.
33. Larson R.S., Corbi A.L., Berman L., Springer T. (1989) Primary structure of the leukocyte function-associated molecule-1 alpha subunit: an integrin with an embedded domain defining a protein superfamily. J Cell Biol 108 : 703 712.
34. Huang C., Springer T.A. (1995) A binding interface on the I domain of lymphocyte function-associated antigen-1 (LFA-1) required for specific interaction with intercellular adhesion molecule 1 (ICAM-1). J Biol Chem 270 : 19008 19016.
35. Xu C.R., Yusuf-Makagiansar H., Hu Y., Jois S.D., Siahaan T.J. (2002) Structural and ICAM-1-docking properties of a cyclic peptide from the I-domain of LFA-1: an inhibitor of ICAM-1/LFA- 1-mediated T-cell adhesion. J Biomol Struct Dyn 19 : 789 799.
36. L I domain and its complex with ICAM-1 reveal a shape-shifting pathway for integrin regulation. Cell 112 : 99 111.
37. Kamata T., Wright R., Takada Y. (1995) Critical threonine and aspartic acid residues within the I domains of beta 2 integrins for interactions with intercellular adhesion molecule 1 (ICAM-1) and C3bi. J Biol Chem 270 : 12531 12535.
38. Edwards C.P., Fisher K.L., Presta L.G., Bodary S.C. (1998) Mapping the intercellular adhesion molecule-1 and -2 binding site on the inserted domain of leukocyte function-associated antigen-1. J Biol Chem 273 : 28937 28944.
39. Peishoff C.E., Ali F.E., Bean J.W., Calvo R., D'Ambrosio C.A., Eggleston D.S., Huang S.M. et al. (1992) Investigation of conformational specificity at GPIIb/IIIa: Evaluation of conformationally constrained RGD peptides. J Med Chem 35 : 3962 3969.
40. 3 integrin ligands: pharmacophore refinement and implications for drug design. J Med Chem 46 : 4393 4404.
41. 5: homology modeling and ligand binding. J Med Chem 47 : 4166 4177.
42. Siahaan T., Tibbetts S.A., Jois S.D.S., Chan M.A., Benedict S.H. (1996) Counter receptor binding domains that block or enhance binding to LFA-1 or ICAM-1. In : Kaumaya P.T.P., Hodges R.S., editors. Peptides: Chemistry Structure and Biology. Kingswinford, UK : Mayflower Scientific p. 792 793.
43. Yusuf-Makagiansar H., Makagiansar I.T., Siahaan T.J. (2001) Inhibition of the adherence of T-lymphocytes to epithelial cells by a cyclic peptide derived from inserted domain of lymphocyte function-associated antigen-1. Inflammation 25 : 203 214.
44. Hogg N., Henderson R., Leitinger B., McDowall A., Porter J., Stanley P. (2002) Mechanisms contributing to the activity of integrins on leukocytes. Immunol Rev 186 : 164 171.
45. Hogg N., Leitinger B. (2001) Shape and shift changes related to the function of leukocyte integrins LFA-1 and Mac-1. J Leukoc Biol 69 : 893 898.
46. Huth J.R., Olejniczak E.T., Mendoza R., Liang H., Harris E.A., Lupher M.L. Jr., Wilson A.E., Fesik S.W., Staunton D.E. (2000) NMR and mutagenesis evidence for an I domain allosteric site that regulates lymphocyte function-associated antigen 1 ligand binding. Proc Natl Acad Sci U S A 97 : 5231 5236.
47. 2. J Cell Biol 167 : 1241 1253.
48. van Kooyk Y., Figdor C.G. (2000) Avidity regulation of integrins: the driving force in leukocyte adhesion. Curr Opin Cell Biol 12 : 542 547.
49. Verkhivker G.M. (2004) Computational analysis of ligand binding dynamics at the intermolecular hot spots with the aid of simulated tempering and binding free energy calculations. J Mol Graph Model 22 : 335 348.
50. Verkhivker G.M. (2007) Computational proteomics of biomolecular interactions in the sequence and structure space of the tyrosine kinome: deciphering the molecular basis of the kinase inhibitors selectivity. Proteins 66 : 912 929.
51. Verkhivker G.M. (2006) Imprint of evolutionary conservation and protein structure variation on the binding function of protein tyrosine kinases. Bioinformatics 22 : 1846 1854.
52. Verkhivker G.M. (2007) In silico profiling of tyrosine kinases binding specificity and drug resistance using Monte Carlo simulations with the ensembles of protein kinase crystal structures. Biopolymers 85 : 333 348.